A detailed history of First National Trust CO transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, First National Trust CO holds 3,544 shares of MDGL stock, worth $1.11 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,544
Previous 3,544 -0.0%
Holding current value
$1.11 Million
Previous $992,000 24.19%
% of portfolio
0.03%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

SELL
$171.37 - $283.23 $149,091 - $246,410
-870 Reduced 19.71%
3,544 $946,000
Q4 2023

Feb 06, 2024

SELL
$120.4 - $237.13 $54,782 - $107,894
-455 Reduced 9.34%
4,414 $1.02 Million
Q1 2023

Apr 26, 2023

BUY
$231.06 - $307.08 $1.13 Million - $1.5 Million
4,869 New
4,869 $1.18 Million

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.34B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track First National Trust CO Portfolio

Follow First National Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on First National Trust CO with notifications on news.